ELVN icon

Enliven Therapeutics
ELVN

Overview Fund Activity

26 hedge funds and large institutions have $7.76M invested in Enliven Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 8 closing their positions.

Holders
26
Holders Change
-5
Holders Change %
-16.13%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MAM
1
Marquette Asset Management
Minnesota
$96K
2
Goldman Sachs
2
Goldman Sachs
New York
$1.07M
3
Rockefeller Capital Management
3
Rockefeller Capital Management
New York
$21K
4
BlackRock
4
BlackRock
New York
$150K
5
PAM
5
Panagora Asset Management
Massachusetts
$14K

Top Sellers

1
NMC
1
NEA Management Company
Maryland
$1.23M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$0
3
PVI
3
Pura Vida Investments
New York
$0
4
LCM
4
Laurion Capital Management
New York
$0
5
Two Sigma Investments
5
Two Sigma Investments
New York
$145K
Name Market Value Shares Shares
Change 		Shares
Change %
PVI
26
Pura Vida Investments
New York
– – -196,635 Closed
LCM
27
Laurion Capital Management
New York
– – -155,183 Closed
PCM
28
Prelude Capital Management
New York
– – -19,545 Closed
Millennium Management
29
Millennium Management
New York
– – -10,307 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– – -830 Closed
Simplex Trading
31
Simplex Trading
Illinois
– – -337 Closed
AA
32
Ancora Advisors
Ohio
– – -112 Closed
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$0 32 – –
CFGS
34
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
35
Wells Fargo
California
$0 84 +6 +8%
1
2